Etanercept SFP in RA Patients

Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials

NCT00357903 ·Status: COMPLETED ·Phase: PHASE3

Evaluating Efficacy and Safety of Etanercept 50 mg Twice Weekly (BIW) in Rheumatoid Arthritis (RA) Subjects Who Are Sub-Optimal Responders to Etanercept 50 mg Once Weekly (QW)

NCT00115219 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

NCT00913458 ·Status: COMPLETED ·Phase: PHASE4

Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

NCT00522184 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

NCT01646385 ·Status: COMPLETED

Study Evaluating the Combination of Etanercept and Methotrexate in Rheumatoid Arthritis Subjects

NCT00252668 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis

NCT00443950 ·Status: COMPLETED ·Phase: PHASE3

An Open-Label Study to Assess the Rate of Failure of an Enbrel® (Etanercept) SureClick™ Auto-injector in Subjects With Rheumatoid Arthritis

NCT00346294 ·Status: COMPLETED ·Phase: PHASE4

A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

NCT01411215 ·Status: TERMINATED

Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission

NCT02373813 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

NCT00459706 ·Status: COMPLETED ·Phase: PHASE3

Open Label, Dose-Regimen Study Evaluating Etanercept 50 mg Once-Weekly In Japanese Subjects With RA

NCT00418717 ·Status: COMPLETED ·Phase: PHASE3

Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

NCT01783015 ·Status: TERMINATED ·Phase: PHASE4

A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis

NCT00484237 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Etanercept With Usual DMARD Therapy in Subjects With Rheumatoid Arthritis in the Asia Pacific Region

NCT00422227 ·Status: COMPLETED ·Phase: PHASE4

Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis

NCT00565409 ·Status: COMPLETED ·Phase: PHASE4

Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

NCT00293722 ·Status: COMPLETED

Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis

NCT00195494 ·Status: COMPLETED ·Phase: PHASE4

This Study is to Investigate the Effect of Etanercept in Early Versus Delayed Referral for Management of Rheumatoid Arthritis Patients.

NCT04267614 ·Status: COMPLETED

Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects

NCT02378506 ·Status: COMPLETED ·Phase: PHASE3

Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients

NCT04428424 ·Status: COMPLETED

A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

NCT00713544 ·Status: COMPLETED ·Phase: PHASE2

16.0040 Ankylosing Spondylitis Study

NCT00356356 ·Status: COMPLETED ·Phase: PHASE3

Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis

NCT00418548 ·Status: COMPLETED ·Phase: PHASE3

Enbrel Liquid Immunogenicity Protocol

NCT00249041 ·Status: COMPLETED ·Phase: PHASE3